Press-release for stocks

crawled date : 2022 - 08 - 08 source : Www.biospace.com

save search

FDA Weekly Review: Bayer, Daiichi Sankyo, AstraZeneca, Gamida Cell and More
Published: 2022-08-08 (Crawled : 23:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -13.63% | O: 0.0% H: 0.0% C: 0.0%
fda

Lantern Pharma Reports Second Quarter 2022 Financial Results and Operational Highlights
Published: 2022-08-08 (Crawled : 22:00) - biospace.com/
LTRN | $5.42 -6.07% -6.46% 240K

Health Technology

| -2.2% | O: -0.55% H: 3.41% C: 3.13%
pharma results

Castle Biosciences Reports Second Quarter 2022 Results
Published: 2022-08-08 (Crawled : 22:00) - biospace.com/
CSTL | $19.28 0.42% 0.41% 130K

Health Technology

| -36.81% | O: 0.72% H: 1.3% C: -7.47%
results

Turning Point Therapeutics Reports Second-Quarter 2022 Financial Results, Provides Operational Updates
Published: 2022-08-08 (Crawled : 22:00) - biospace.com/
TPTX | $76.01 -0.03%

Health Technology

| 0.98% | O: -0.27% H: 0.0% C: 0.0%
therapeutics

Guardant Health to Participate in the UBS Genomics 2.0 and MedTech Innovations Summit Conference
Published: 2022-08-08 (Crawled : 22:00) - biospace.com/
GH M | $16.08 -3.54% -3.67% 1.9M

Health Services

| -69.63% | O: 1.28% H: 6.88% C: 1.68%
conference health genomics

Atara Biotherapeutics Announces Second Quarter 2022 Financial Results and Corporate Strategy Update
Published: 2022-08-08 (Crawled : 22:00) - biospace.com/
ATRA | $0.6755 -2.34% -2.4% 1.6M

Health Technology

| -80.81% | O: 4.07% H: 4.47% C: 1.4%
update results

Vaxcyte Reports Second Quarter 2022 Financial Results and Provides Business Update
Published: 2022-08-08 (Crawled : 22:00) - biospace.com/
PPRUF | $358.55 37.56% 1.5K

Consumer Non-Durables

| -34.06% | O: 5.95% H: 0.0% C: -1.24%
PPRUY | $36.0023 -0.11% 220K

Manufacturing

| -34.92% | O: 1.46% H: 0.62% C: -0.53%
PCVX | $60.82 0.33% 0.33% 1.3M

Health Technology

| 134.59% | O: 0.62% H: 0.13% C: -0.65%
STRO | $3.635 -3.58% -3.71% 520K

Health Technology

| -36.98% | O: 0.69% H: 10.52% C: 6.72%
update results

Denali Therapeutics Reports Second Quarter 2022 Financial Results and Business Highlights
Published: 2022-08-08 (Crawled : 22:00) - biospace.com/
MS | News | $90.66 0.44% 0.07% 8.1M

Finance

| 5.26% | O: 0.73% H: 0.53% C: -0.84%
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -5.91% | O: -0.14% H: 0.0% C: 0.0%
DNLI | $15.98 -3.74% -3.88% 1.5M

Health Technology

| -55.24% | O: 1.03% H: 7.14% C: 3.13%
therapeutics results

Augmedix Reports Second Quarter 2022 Financial Results
Published: 2022-08-08 (Crawled : 22:00) - biospace.com/
AUGX M | $2.97 -1.33% -1.35% 290K

| 99.33% | O: 0.0% H: 0.12% C: 0.0%
results

Gravity Branding names Novartis’ Vijoice® (alpelisib)Expert naming process valued in fast-tracked approval as drug clears FDA regulatory hurdles
Published: 2022-08-08 (Crawled : 22:00) - biospace.com/
SRE | News | $70.08 2.4% -0.71% 3.1M

Utilities

| -56.14% | O: 0.7% H: 0.68% C: 0.03%
vijoice fda drug approval

Acumen Pharmaceuticals to Report Second Quarter 2022 Financial Results on August 15, 2022
Published: 2022-08-08 (Crawled : 22:00) - biospace.com/
ABOS | $3.14 -0.63% -0.64% 310K

Professional, Scientific, and T...

| -39.66% | O: 1.53% H: 4.87% C: -0.57%
report results

Precigen Reports Second Quarter and First Half 2022 Financial Results
Published: 2022-08-08 (Crawled : 22:00) - biospace.com/
PGEN | $1.33 0.76% 0.75% 1M

Health Technology

| -35.75% | O: 0.0% H: 2.42% C: -0.97%
results

IGM Biosciences Announces Second Quarter 2022 Financial Results and Provides Corporate Update
Published: 2022-08-08 (Crawled : 22:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -5.91% | O: -0.14% H: 0.0% C: 0.0%
IGMS | $7.2 -2.83% -2.92% 220K

Health Technology

| -61.97% | O: 1.11% H: 9.93% C: 8.57%
update results

Novavax Reports Second Quarter 2022 Financial Results and Operational Highlights
Published: 2022-08-08 (Crawled : 22:00) - biospace.com/
NVAX | $3.99 2.57% 2.51% 2.9M

Health Technology

| -93.41% | O: 0.91% H: 3.17% C: -5.87%
results

Clearside Biomedical Enters into Non-Dilutive Financing Agreement with HealthCare Royalty Partners for up to $65 Million- Transaction Supports Progression of CLS-AX Clinical Program -
Published: 2022-08-08 (Crawled : 22:00) - biospace.com/
CLSD P | $1.29 -2.27% -2.33% 230K

Health Technology

| -21.56% | O: 2.4% H: 1.17% C: -4.09%
cls-ax program agreement

Hanger Reports Second Quarter 2022 Financial Results
Published: 2022-08-08 (Crawled : 21:00) - biospace.com/
HNGR | $18.72 0.0%

Health Services

| 0.81% | O: 0.38% H: 0.0% C: 0.0%
results

Acadia Pharmaceuticals Reports Second Quarter 2022 Financial Results
Published: 2022-08-08 (Crawled : 21:00) - biospace.com/
ACAD | $16.82 -1.47% -1.49% 3.5M

Health Technology

| 2.31% | O: -2.49% H: 5.86% C: 3.68%
results